Latest News

Baupost Group Holds 35% Stake In Keryx Pharmaceuticals

Baupost Group Holds 35% Stake In Keryx Pharmaceuticals

Baupost Group, the investment management firm headed by Seth Klarman increased its stake in Keryx Pharmaceuticals based on its latest 13D filing with the Securities and Exchange Commission (SEC). Based on the filing, Baupost Group, SAK Corporation, and Mr. Klarman […]

Chart via S&P CapIQ

Reputation Risk Drives Credit Suisse Strategy

Reputation Risk Drives Credit Suisse Strategy by John Heilprin, swissinfo.ch Switzerland’s second-biggest bank is getting back to what it has done best in a bid to restore investor confidence by reshaping its business and boosting profitability. In a word, it’s […]

China’s Growth – Miracle Or Mirage

China’s Growth – Miracle Or Mirage

China’s Growth – Miracle Or Mirage by 720 Global “Pay no attention to the man behind the curtain!” – L. Frank Baum (The Wizard of Oz) Once again, the release of China’s GDP on October 19th brought few surprises. Year […]